MediPal Holdings Corporation
7459
Rang în acțiuni
#4283
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898,... Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
Preț acțiune
$20.40
Capitalizare de piață
$3.70B
Schimbare (1 zi)
0.42%
Schimbare (1 an)
19.72%
Țară
JP
Tranzacționează MediPal Holdings Corporation (7459)
Categorie
Healthcare
Raport P/E pentru MediPal Holdings Corporation (7459)
Raport P/E la data de October 2026 TTM: 13.55
Conform celor mai recente rapoarte financiare și prețului acțiunilor MediPal Holdings Corporation, raportul P/E actual (TTM) este 13.55. La sfârșitul anului 2024, compania avea un P/E de 11.83.
Istoricul raportului P/E pentru MediPal Holdings Corporation din 2005 până în 2026
Raportul P/E la sfârșitul fiecărui an
| An | Raport P/E | Schimbă |
|---|---|---|
| 2026 (TTM) | 13.55 | 12.11% |
| 2025 | 12.09 | 2.20% |
| 2024 | 11.83 | 21.17% |
| 2023 | 9.76 | -32.12% |
| 2022 | 14.38 | -22.86% |
| 2021 | 18.64 | 62.38% |
| 2020 | 11.48 | -37.22% |
| 2019 | 18.28 | 29.27% |
| 2018 | 14.14 | 3.79% |
| 2017 | 13.63 | 3.92% |
| 2016 | 13.11 | -12.25% |
| 2015 | 14.94 | 6.79% |
| 2014 | 13.99 | -9.39% |
| 2013 | 15.44 | -28.55% |
| 2012 | 21.62 | -78.66% |
| 2011 | 101.31 | -23.98% |
| 2010 | 133.28 | 563.24% |
| 2009 | 20.09 | 32.62% |
| 2008 | 15.15 | -44.08% |
| 2007 | 27.10 | 41.90% |
| 2006 | 19.09 | -36.81% |
| 2005 | 30.21 | 0.00% |
Raportul P/E pentru companii similare sau concurenți
| Companie | P/E Ratio | Diferență P/E Ratio | Țara |
|---|---|---|---|
| 26.02 | 91.98% |
US
|
|
| - | - |
US
|
|
| 34.08 | 151.42% |
US
|
|
| - | - |
US
|
|
| 45.62 | 236.56% |
AU
|
Cum interpretezi un P/E ratio?
Raportul Preț/Câștig (P/E Ratio) măsoară relația dintre prețul acțiunii unei companii și câștigul pe acțiune.
Un P/E scăzut dar pozitiv indică o companie cu profituri mari în raport cu evaluarea actuală și ar putea fi subevaluată. Un P/E negativ mare (aproape de 0) indică pierderi majore.
Companiile cu un P/E peste 30 sau negativ sunt considerate în general „acțiuni de creștere”, adică investitorii se așteaptă la creștere sau profitabilitate viitoare.
Companiile cu un P/E pozitiv sub 10 sunt considerate „acțiuni de valoare”, adică sunt deja profitabile, dar cu șanse mici de creștere suplimentară.